Skip to main content
Top
Published in: HSS Journal ® 1/2019

01-02-2019 | Opioids | Opioid Prescribing and Pain Management / Commentary

Opioid Prescribing and Physician Autonomy: A Quality of Care Perspective

Authors: Mark Barnes, JD, LLM, John Giampa, JD, MSPH, Minal Caron, JD

Published in: HSS Journal ® | Issue 1/2019

Login to get access

Excerpt

The public health and social harms resulting from misuse of opioids, particularly substance use disorders related to prescription opioids, have been under intense scrutiny in recent years [9, 53]. Some individuals who receive prescription opioids also use heroin, which has additional risks due to unknown potency and adulteration [7]. Center for Disease Control and Prevention (CDC) statistics indicate that 115 Americans die of an opioid overdose each day [8]. Although the dominant media narrative assigns much of the blame to overprescribing or misprescribing by physicians, the news media less than 20 years ago frequently castigated physicians for failing to provide sufficient pain control and dismissed or ignored the possibility that inappropriate deployment of opioids could lead to addiction [36, 44, 67]. As one article published in American Family Physician in 2000 stated: “Despite recent advances in the understanding of pain management, patients continue to suffer needlessly, primarily because of improper management and inadequate pain medication” [4, 44]. In 2001, a story appeared in the Chicago Tribune reporting that “[a] jury awarded $1.5 million to the family of an 85-year-old man who accused his doctor of not prescribing enough pain medication during his final days” [36]. …
Appendix
Available only for authorised users
Literature
1.
go back to reference 21 U.S.C. §§ 823, 827–29 (West 2012); 21 C.F.R. § 1306.04(a) (2013); 21 C.F.R. § 1305 et seq. (2013); 42 C.F.R. § 8.12 (2013). 21 U.S.C. §§ 823, 827–29 (West 2012); 21 C.F.R. § 1306.04(a) (2013); 21 C.F.R. § 1305 et seq. (2013); 42 C.F.R. § 8.12 (2013).
2.
go back to reference 42 C.F.R §482.12 (2011); 42 C.F.R §482.21 (2011); 42 C.F.R §482.22 (2011). 42 C.F.R §482.12 (2011); 42 C.F.R §482.21 (2011); 42 C.F.R §482.22 (2011).
4.
go back to reference Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic A. Contralateral prophylactic mastectomy: challenging considerations for the surgeon. Ann Surg Oncol. 2015;22(10):3208–3212.CrossRefPubMedPubMedCentral Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic A. Contralateral prophylactic mastectomy: challenging considerations for the surgeon. Ann Surg Oncol. 2015;22(10):3208–3212.CrossRefPubMedPubMedCentral
5.
go back to reference Barnett ML, Gray J, Zink A, Jena A. Coupling policymaking with evaluation—the case of the opioid crisis. N Engl J Med. 2017; 377:2306–2309.CrossRefPubMed Barnett ML, Gray J, Zink A, Jena A. Coupling policymaking with evaluation—the case of the opioid crisis. N Engl J Med. 2017; 377:2306–2309.CrossRefPubMed
6.
go back to reference Brady J, Wunsch H, DiMaggio C, Lang BH, Giglio J, Li G. Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 2014;129(2):139–147.CrossRefPubMedPubMedCentral Brady J, Wunsch H, DiMaggio C, Lang BH, Giglio J, Li G. Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 2014;129(2):139–147.CrossRefPubMedPubMedCentral
7.
go back to reference Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016; 160:127–134.CrossRefPubMedPubMedCentral Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016; 160:127–134.CrossRefPubMedPubMedCentral
8.
go back to reference CDC/NCHS, National Vital Statistics System, Mortality. CDC Wonder, Atlanta: US Department of Health and Human Services, CDC; 2017. CDC/NCHS, National Vital Statistics System, Mortality. CDC Wonder, Atlanta: US Department of Health and Human Services, CDC; 2017.
9.
go back to reference Center for Behavioral Health Statistics and Quality (CBHSQ). 2015 National Survey on Drug Use and Health: Detailed Tables. Rockville: Substance Abuse and Mental Health Services Administration; 2016. Center for Behavioral Health Statistics and Quality (CBHSQ). 2015 National Survey on Drug Use and Health: Detailed Tables. Rockville: Substance Abuse and Mental Health Services Administration; 2016.
10.
go back to reference Centers for Medicare & Medicaid Services (CMS). Medicare and Medicaid programs; hospital conditions of participation: quality assessment and performance improvement. Final rule. Fed Regist. 2003;68(16):3435–3455. Centers for Medicare & Medicaid Services (CMS). Medicare and Medicaid programs; hospital conditions of participation: quality assessment and performance improvement. Final rule. Fed Regist. 2003;68(16):3435–3455.
12.
go back to reference Chan LS, Elabiad M, Zheng L, et al. A medical staff peer review system in a public teaching hospital—an internal quality improvement tool. J Healthc Qual. 2014;36(1):37–44. Chan LS, Elabiad M, Zheng L, et al. A medical staff peer review system in a public teaching hospital—an internal quality improvement tool. J Healthc Qual. 2014;36(1):37–44.
13.
go back to reference Chang HY, Lyapustina T, Rutkow L, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis. Drug Alcohol Depend. 2016;165:1–8.CrossRefPubMedPubMedCentral Chang HY, Lyapustina T, Rutkow L, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis. Drug Alcohol Depend. 2016;165:1–8.CrossRefPubMedPubMedCentral
16.
go back to reference Credentialing and Privileging—Requirements for Physician Assistants and Advanced Practice Registered Nurses. The Joint Commission. Credentialing and Privileging—Requirements for Physician Assistants and Advanced Practice Registered Nurses. The Joint Commission.
17.
go back to reference Crosswalk to Performance Improvement. The Joint Commission. Crosswalk to Performance Improvement. The Joint Commission.
18.
go back to reference Davis CS, Carr DH. Self-regulating profession? Administrative discipline of “pill mill” physicians in Florida. Subst Abus. 2017;38(3):265–268.CrossRefPubMed Davis CS, Carr DH. Self-regulating profession? Administrative discipline of “pill mill” physicians in Florida. Subst Abus. 2017;38(3):265–268.CrossRefPubMed
19.
go back to reference Delcher C, Wagenaar AC, Goldberger BA, Cook RL, Maldonado-Molina MM. Abrupt decline in oxycodone-caused mortality after implementation of Florida’s prescription drug monitoring program. Drug Alcohol Depend. 2015;150:63–68.CrossRefPubMed Delcher C, Wagenaar AC, Goldberger BA, Cook RL, Maldonado-Molina MM. Abrupt decline in oxycodone-caused mortality after implementation of Florida’s prescription drug monitoring program. Drug Alcohol Depend. 2015;150:63–68.CrossRefPubMed
21.
go back to reference Deyo-Svendsen, Phillips MR, Albright JK, Schilling KA, Palmer, KB. A systematic approach to clinical peer review in a critical access hospital. Qual Manag Health Care. 2016;25(4):213–218.CrossRefPubMedPubMedCentral Deyo-Svendsen, Phillips MR, Albright JK, Schilling KA, Palmer, KB. A systematic approach to clinical peer review in a critical access hospital. Qual Manag Health Care. 2016;25(4):213–218.CrossRefPubMedPubMedCentral
22.
go back to reference Edwards MT. Clinical peer review program self-evaluation for US hospitals. Am J Med Qual. 2010;25(6):474–480.CrossRefPubMed Edwards MT. Clinical peer review program self-evaluation for US hospitals. Am J Med Qual. 2010;25(6):474–480.CrossRefPubMed
23.
go back to reference Finley E, Garcia A, Rosen K, McGeary D, Pugh MJ, Potter JS. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420.CrossRefPubMedPubMedCentral Finley E, Garcia A, Rosen K, McGeary D, Pugh MJ, Potter JS. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420.CrossRefPubMedPubMedCentral
24.
go back to reference Fudin J, Atkinson TJ. Opioid prescribing levels off, but is less really more? Pain Medicine. 2014;15(2):184–187.CrossRefPubMed Fudin J, Atkinson TJ. Opioid prescribing levels off, but is less really more? Pain Medicine. 2014;15(2):184–187.CrossRefPubMed
26.
go back to reference García MC, Dodek AB, Kowalski T, et al. Declines in opioid prescribing after a private insurer policy change—Massachusetts, 2011–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1125–1131. García MC, Dodek AB, Kowalski T, et al. Declines in opioid prescribing after a private insurer policy change—Massachusetts, 2011–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1125–1131.
28.
go back to reference Grant D, Alfred KC. Sanctions and recidivism: an evaluation of physician discipline by state medical boards. J Health Polit Policy Law. 2007;32(5):867–885.CrossRefPubMed Grant D, Alfred KC. Sanctions and recidivism: an evaluation of physician discipline by state medical boards. J Health Polit Policy Law. 2007;32(5):867–885.CrossRefPubMed
29.
go back to reference Griggs C, Weiner S, Feldman J. Prescription drug monitoring programs: examining limitations and future approaches. West J Emerg Med. 2015;16(1):67–70.CrossRefPubMedPubMedCentral Griggs C, Weiner S, Feldman J. Prescription drug monitoring programs: examining limitations and future approaches. West J Emerg Med. 2015;16(1):67–70.CrossRefPubMedPubMedCentral
30.
go back to reference Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and do not know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34–47.CrossRefPubMedPubMedCentral Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and do not know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34–47.CrossRefPubMedPubMedCentral
31.
go back to reference Haffajee R. Preventing opioid misuse with prescription drug monitoring programs: a framework for evaluating the success of state public health laws. Hastings Law Journal. 2016;67(6):1621–1694. Haffajee R. Preventing opioid misuse with prescription drug monitoring programs: a framework for evaluating the success of state public health laws. Hastings Law Journal. 2016;67(6):1621–1694.
32.
go back to reference Harris JA, Byhoff E. Variations by state in physician disciplinary actions by US medical licensure boards. BMJ Qual Saf. 2017;26(3):200–208.CrossRefPubMed Harris JA, Byhoff E. Variations by state in physician disciplinary actions by US medical licensure boards. BMJ Qual Saf. 2017;26(3):200–208.CrossRefPubMed
33.
go back to reference Hawk K, D’Onofrio G, Fiellin DA, et al. Past-year prescription drug monitoring program opioid prescriptions and self-reported opioid use in an emergency department population with opioid use disorder. Acad Emerg Med. 2018;25(5):508–516.CrossRefPubMed Hawk K, D’Onofrio G, Fiellin DA, et al. Past-year prescription drug monitoring program opioid prescriptions and self-reported opioid use in an emergency department population with opioid use disorder. Acad Emerg Med. 2018;25(5):508–516.CrossRefPubMed
37.
go back to reference Knudsen HK, Havens JR, Lofwall MR, Studts JL, Walsh SL. Buprenorphine physician supply: relationship with state-level prescription opioid mortality. Drug Alcohol Depend. 2017;173 Suppl 1:S55–S64.CrossRefPubMedPubMedCentral Knudsen HK, Havens JR, Lofwall MR, Studts JL, Walsh SL. Buprenorphine physician supply: relationship with state-level prescription opioid mortality. Drug Alcohol Depend. 2017;173 Suppl 1:S55–S64.CrossRefPubMedPubMedCentral
38.
go back to reference Law MT, Hansen ZK. Medical licensing board characteristics and physician discipline: an empirical analysis. J Health Polit Policy Law. 2010;35(1):63–93.CrossRefPubMed Law MT, Hansen ZK. Medical licensing board characteristics and physician discipline: an empirical analysis. J Health Polit Policy Law. 2010;35(1):63–93.CrossRefPubMed
39.
go back to reference Leibert M. Performance of state medical boards: implications for hospitals and health systems. Hosp Top. 2010;88:4:107–115. Leibert M. Performance of state medical boards: implications for hospitals and health systems. Hosp Top. 2010;88:4:107–115.
41.
go back to reference Lyapustina T, Rutkow L, Chang HY, et al. Effect of a “pill mill” law on opioid prescribing and utilization: the case of Texas. Drug Alcohol Depend. 2016;159:190–197. Lyapustina T, Rutkow L, Chang HY, et al. Effect of a “pill mill” law on opioid prescribing and utilization: the case of Texas. Drug Alcohol Depend. 2016;159:190–197.
42.
go back to reference Maughan B, Bachhuber MA, Mitra N, Starrels JL. Prescription monitoring programs and emergency department visits involving opioids, 2004–2011. Drug Alcohol Depend. 2015;156:282–288.CrossRefPubMedPubMedCentral Maughan B, Bachhuber MA, Mitra N, Starrels JL. Prescription monitoring programs and emergency department visits involving opioids, 2004–2011. Drug Alcohol Depend. 2015;156:282–288.CrossRefPubMedPubMedCentral
43.
44.
go back to reference Miller KE. Physician attitudes a barrier to pain management. Am Fam Physician. 2000;62(10):2317–2318. Miller KE. Physician attitudes a barrier to pain management. Am Fam Physician. 2000;62(10):2317–2318.
45.
47.
go back to reference N.Y. Pub. Health Law § 230; § N.Y. Educ. Law § 6532. N.Y. Pub. Health Law § 230; § N.Y. Educ. Law § 6532.
48.
49.
50.
51.
52.
go back to reference Nam YH, Shea DG, Shi Y, Moran JR. State prescription drug monitoring programs and fatal drug overdoses. Am J Manag Care. 2017;23(5):297–303.PubMed Nam YH, Shea DG, Shi Y, Moran JR. State prescription drug monitoring programs and fatal drug overdoses. Am J Manag Care. 2017;23(5):297–303.PubMed
53.
go back to reference National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Phillips JK, Ford MA, Bonnie RJ, editors. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): National Academies Press (US) 2017. 4, Trends in opioid use, harms, and treatment. Available from https://www.ncbi.nlm.nih.gov/books/NBK458661. Accessed 10 Sept 2018. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Phillips JK, Ford MA, Bonnie RJ, editors. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): National Academies Press (US) 2017. 4, Trends in opioid use, harms, and treatment. Available from https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK458661. Accessed 10 Sept 2018.
55.
go back to reference Neven D, Paulozzi L, Howell D, et al. A randomized controlled trial of a citywide emergency department care coordination program to reduce prescription opioid related emergency department visits. J Emerg Med. 2016;51(5):498–507.CrossRefPubMedPubMedCentral Neven D, Paulozzi L, Howell D, et al. A randomized controlled trial of a citywide emergency department care coordination program to reduce prescription opioid related emergency department visits. J Emerg Med. 2016;51(5):498–507.CrossRefPubMedPubMedCentral
56.
go back to reference Nolan SW, Burkard JF, Clark MJ, Davidson JE, Agan DL. Effect of morbidity and mortality peer review on nurse accountability and ventilator-associated pneumonia rates. J Nurs Adm. 2010;40(9):37483.CrossRef Nolan SW, Burkard JF, Clark MJ, Davidson JE, Agan DL. Effect of morbidity and mortality peer review on nurse accountability and ventilator-associated pneumonia rates. J Nurs Adm. 2010;40(9):37483.CrossRef
58.
go back to reference Osborn SR, Yu J, Williams B, Vasilyadis M, Blackmore CC. Changes in provider prescribing patterns after implementation of an emergency department prescription opioid policy. J Emerg Med. 2017;52(4):538–546.CrossRefPubMed Osborn SR, Yu J, Williams B, Vasilyadis M, Blackmore CC. Changes in provider prescribing patterns after implementation of an emergency department prescription opioid policy. J Emerg Med. 2017;52(4):538–546.CrossRefPubMed
59.
go back to reference Paone D, Tuazon E, Kattan J, et al. Decrease in rate of opioid analgesic overdose deaths—Staten Island, New York City, 2011–2013. MMWR Morb Mortal Wkly Rep. 2015;64(18):491–494.PubMedPubMedCentral Paone D, Tuazon E, Kattan J, et al. Decrease in rate of opioid analgesic overdose deaths—Staten Island, New York City, 2011–2013. MMWR Morb Mortal Wkly Rep. 2015;64(18):491–494.PubMedPubMedCentral
60.
go back to reference Penti B, Liebschutz JM, Kopcza B, Xuan Z, Odell C, Saper R. Novel peer review method for improving controlled substance prescribing in primary care. J Opioid Manag. 2016;12(4):269–279.CrossRefPubMed Penti B, Liebschutz JM, Kopcza B, Xuan Z, Odell C, Saper R. Novel peer review method for improving controlled substance prescribing in primary care. J Opioid Manag. 2016;12(4):269–279.CrossRefPubMed
61.
go back to reference N.Y. Pub. Health Law § 3343-a; 10 NYCRR § 80.63; Fla. Stat. § 893.055 (2018); 37 Tex. Admin. Code §§ 13.71–86 (West 2005). N.Y. Pub. Health Law § 3343-a; 10 NYCRR § 80.63; Fla. Stat. § 893.055 (2018); 37 Tex. Admin. Code §§ 13.71–86 (West 2005).
62.
go back to reference Physician and Physician Assistants Disciplinary and Other Actions. Department of Health. NY State: Department of Health. Revised July 2012. Physician and Physician Assistants Disciplinary and Other Actions. Department of Health. NY State: Department of Health. Revised July 2012.
63.
go back to reference Physician Information (Arthur Mercado). NY State: Department of Health. Physician Information (Arthur Mercado). NY State: Department of Health.
64.
go back to reference Physician Information (Gregory Denzel). NY State: Department of Health. Physician Information (Gregory Denzel). NY State: Department of Health.
65.
go back to reference Physician Information (Liviu Nastase). NY State: Department of Health. Physician Information (Liviu Nastase). NY State: Department of Health.
66.
go back to reference Pomerleau AC, Nelson LS, Hoppe JA, Salzman M, Weiss PS, Perrone J. The impact of prescription drug monitoring programs and prescribing guidelines on emergency department opioid prescribing. Pain Med. 2017;18(5):889–897.PubMed Pomerleau AC, Nelson LS, Hoppe JA, Salzman M, Weiss PS, Perrone J. The impact of prescription drug monitoring programs and prescribing guidelines on emergency department opioid prescribing. Pain Med. 2017;18(5):889–897.PubMed
67.
go back to reference Porter J, Hershel J. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123.PubMed Porter J, Hershel J. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123.PubMed
68.
go back to reference Quality Assessment and Performance Improvement (QAPI) Program Description. Peach State Health Plan: 2017. Quality Assessment and Performance Improvement (QAPI) Program Description. Peach State Health Plan: 2017.
69.
go back to reference Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009;3:41–51.PubMedPubMedCentral Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009;3:41–51.PubMedPubMedCentral
70.
go back to reference Roe v. Wade and the right to abortion. National Women’s Law Center. January 18, 2018. Roe v. Wade and the right to abortion. National Women’s Law Center. January 18, 2018.
71.
go back to reference Rose ME. Are prescription opioids driving the opioid crisis? Assumptions vs. facts Pain Medicine. 2017;19(4):793–807.CrossRef Rose ME. Are prescription opioids driving the opioid crisis? Assumptions vs. facts Pain Medicine. 2017;19(4):793–807.CrossRef
72.
go back to reference S.D. Codified Laws § 34-23A-10.1; Mo. Ann. Stat. § 188.039. S.D. Codified Laws § 34-23A-10.1; Mo. Ann. Stat. § 188.039.
73.
go back to reference Saunders K, Shortreed S, Thielke S, et al. Evaluation of health plan interventions to influence chronic opioid therapy prescribing. Clin J Pain. 2015;31(9):820–829.PubMedPubMedCentral Saunders K, Shortreed S, Thielke S, et al. Evaluation of health plan interventions to influence chronic opioid therapy prescribing. Clin J Pain. 2015;31(9):820–829.PubMedPubMedCentral
75.
go back to reference Soelberg CD, Brown RE Jr., Du Vivier D, Meyer JE, Ramachandran BK. The US opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125(5):1675–1681.CrossRefPubMed Soelberg CD, Brown RE Jr., Du Vivier D, Meyer JE, Ramachandran BK. The US opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125(5):1675–1681.CrossRefPubMed
76.
go back to reference Spooner L, Fernandes K, Martins D, et al. High-dose opioid prescribing and opioid-related hospitalization: a population-based study. PLOS One. 2016;12(1):e0170834. Spooner L, Fernandes K, Martins D, et al. High-dose opioid prescribing and opioid-related hospitalization: a population-based study. PLOS One. 2016;12(1):e0170834.
78.
go back to reference State Opioid Prescribing Policy: Florida. Florida Academy of Pain Medicine. State Opioid Prescribing Policy: Florida. Florida Academy of Pain Medicine.
79.
go back to reference Substance Abuse and Mental Health Services Administration. Prescription drug monitoring programs: a guide for healthcare providers. In Brief. 2017;10:1.CrossRef Substance Abuse and Mental Health Services Administration. Prescription drug monitoring programs: a guide for healthcare providers. In Brief. 2017;10:1.CrossRef
80.
go back to reference Sun BC, Charlesworth CJ, Lupulescu-Mann N, et al. Effect of automated prescription drug monitoring program queries on emergency department opioid prescribing. Ann Emerg Med. 2018;71(3):337–347.e6.CrossRefPubMed Sun BC, Charlesworth CJ, Lupulescu-Mann N, et al. Effect of automated prescription drug monitoring program queries on emergency department opioid prescribing. Ann Emerg Med. 2018;71(3):337–347.e6.CrossRefPubMed
81.
go back to reference Tex. Health & Safety Code Ann. § 171.012; Wis. Stat. Ann. § 253.10. Tex. Health & Safety Code Ann. § 171.012; Wis. Stat. Ann. § 253.10.
83.
go back to reference Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–2261.CrossRefPubMed Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–2261.CrossRefPubMed
85.
go back to reference Vyas D, Hozain AE. Clinical peer review in the United States: history, legal development and subsequent abuse. World J Gastroenterol. 2014;20(21):6357–6363.CrossRefPubMedPubMedCentral Vyas D, Hozain AE. Clinical peer review in the United States: history, legal development and subsequent abuse. World J Gastroenterol. 2014;20(21):6357–6363.CrossRefPubMedPubMedCentral
87.
go back to reference Waisbren SJ. The opioid epidemic and the Minnesota Board of Medical Practice. Minn Med. 2016;99(3):39–41.PubMed Waisbren SJ. The opioid epidemic and the Minnesota Board of Medical Practice. Minn Med. 2016;99(3):39–41.PubMed
88.
go back to reference Webster L. The pain epidemic versus the opioid crisis; in Worley SL. New directions in the treatment of chronic pain: National pain strategy will guide prevention, management, and research. PT. 2016;41:107–115. Webster L. The pain epidemic versus the opioid crisis; in Worley SL. New directions in the treatment of chronic pain: National pain strategy will guide prevention, management, and research. PT. 2016;41:107–115.
89.
go back to reference Wollschlaeger v. Governor, Fla., 848 F.3d 1293 (11th Cir. 2017). Wollschlaeger v. Governor, Fla., 848 F.3d 1293 (11th Cir. 2017).
Metadata
Title
Opioid Prescribing and Physician Autonomy: A Quality of Care Perspective
Authors
Mark Barnes, JD, LLM
John Giampa, JD, MSPH
Minal Caron, JD
Publication date
01-02-2019
Publisher
Springer US
Published in
HSS Journal ® / Issue 1/2019
Print ISSN: 1556-3316
Electronic ISSN: 1556-3324
DOI
https://doi.org/10.1007/s11420-018-09666-8

Other articles of this Issue 1/2019

HSS Journal ® 1/2019 Go to the issue

Opioid Prescribing and Pain Management / Consensus Statement

Consensus Statement: Toward Opioid-Free Arthroplasty: A Leadership Forum

Opioid prescribing and pain management / commentary

Opioids and Ethics: Is Opioid-Free the Only Responsible Arthroplasty?